PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells

Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers

(2011) V. Rockova et al.   BLOOD

PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia

(2010) Kankan Wang et al.   CANCER CELL

PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia

(2010) Joost H.A. Martens et al.   CANCER CELL

A functional RNAi screen identifies hexokinase 1 as a modifier of type II apoptosis

(2010) Anja Schindler et al.   CELLULAR SIGNALLING

Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group

(2010) Torsten Haferlach et al.   JOURNAL OF CLINICAL ONCOLOGY

The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1

(2010) M Jenal et al.   LEUKEMIA

CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation

(2010) Jasmin Batliner et al.   MOLECULAR IMMUNOLOGY

Regulation and Cytoprotective Role of Hexokinase III

(2010) Eugene Wyatt et al.   PLoS One

Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate

(2009) Zhao Chen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples

(2009) Jacqueline E. Payton et al.   JOURNAL OF CLINICAL INVESTIGATION

Evaluation of the Role of Hexokinase Type II in Cellular Proliferation and Apoptosis Using Human Hepatocellular Carcinoma Cell Lines

(2009) K. J. Ahn et al.   JOURNAL OF NUCLEAR MEDICINE

NDRG1/2 expression is inhibited in primary acute myeloid leukemia

(2009) Mario P. Tschan et al.   LEUKEMIA RESEARCH

Downregulation of the Hexokinase II Gene Sensitizes Human Colon Cancer Cells to 5-Fluorouracil

(2008) Qiu-Ping Peng et al.   CHEMOTHERAPY

PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity

(2008) M P Tschan et al.   ONCOGENE

PU.1: A crucial and versatile player in hematopoiesis and leukemia

(2007) Philippe Kastner et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY